About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Hematology/Oncology Clinics of North America
›
Top Articles
Hematology/Oncology Clinics of North America
Hematology
,
Oncology
3.1
(top 5%)
Impact Factor
3.4
(top 5%)
extended IF
87
(top 4%)
H-Index
516
authors
3K
papers
56.2K
citations
5K
citing journals
28.5K
citing authors
Most Cited Articles of Hematology/Oncology Clinics of North America
Title
Year
Citations
Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis
1998
320
Aging and cancer in America. Demographic and epidemiologic perspectives
2000
317
The Global Burden of Anemia
2016
313
Neuroblastoma: biology, prognosis, and treatment
2010
279
Cytomegalovirus in hematopoietic stem cell transplant recipients
2011
243
Anemia of inflammation
2014
228
Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis
1998
207
BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance
1995
205
Tumors After Renal and Cardiac Transplantation
1993
188
Chronic granulomatous disease
2013
175
Coagulation 2006: a modern view of hemostasis
2007
173
Glucose-6-Phosphate Dehydrogenase Deficiency
2016
170
Epidemiology of Bladder Cancer
1992
166
Dyskeratosis congenita
2009
151
Pathophysiology and treatment of graft-versus-host disease
1999
149
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
2000
148
The antifolates
2012
147
Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis
2009
147
BRAF signaling and targeted therapies in melanoma
2009
143
Central nervous system disease in Langerhans cell histiocytosis
1998
139
Promoting a healthy lifestyle among cancer survivors
2008
139
The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society
1998
138
Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia
1999
138
Solitary plasmacytoma of bone and extramedullary plasmacytoma
1999
135
Cancer and aging. An evolving panorama
2000
132
previous
2005
2006
2007
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.